Karpova, D., Bräuninger, S., Wiercinska, E., Krämer, A., Stock, B., Graff, J., . . . Bonig, H. (2017). Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial. J Transl Med.
استشهاد بنمط شيكاغوKarpova, Darja, et al. "Mobilization of Hematopoietic Stem Cells With the Novel CXCR4 Antagonist POL6326 (balixafortide) in Healthy Volunteers—results of a Dose Escalation Trial." J Transl Med 2017.
MLA استشهادKarpova, Darja, et al. "Mobilization of Hematopoietic Stem Cells With the Novel CXCR4 Antagonist POL6326 (balixafortide) in Healthy Volunteers—results of a Dose Escalation Trial." J Transl Med 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.